Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An Update from the childhood cancer survivor study

Radiation Research

Volumn 174, Issue 6 A, 2010, Pages 741-752

  Bhatti, Parveen ^a,b   Veiga, Lene H S ^b   Ronckers, Cécile M ^b,c   Sigurdson, Alice J ^b   Stovall, Marilyn ^d   Smith, Susan A ^d   Weathers, Rita ^d   Leisenring, Wendy ^a   Mertens, Ann C ^e   Hammond, Sue ^f   Friedman, Debra L ^g   Neglia, Joseph P ^h   Meadows, Anna T ⁱ   Donaldson, Sarah S ^j   Sklar, Charles A ^k   Robison, Leslie L ^l   Inskip, Peter D ^b  

^a USA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Dutch Childhood Oncology Group   (Netherlands)

^d UNIVERSITY OF TEXAS   (United States)

^e EMORY UNIVERSITY   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g VANDERBILT INGRAM CANCER CENTER   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j STANFORD CANCER INSTITUTE   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; BONE CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; DOSE RESPONSE; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIATION RESPONSE; SCHOOL CHILD; SECOND CANCER; SOFT TISSUE SARCOMA; THYROID CANCER;

AGE FACTORS; CHILD; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RISK; SURVIVORS; THYROID NEOPLASMS;

EID: 78650032075     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2240.1     Document Type: Article

References (29)

1. C. M. Ronckers, A. J. Sigurdson, M. Stovall, S. A. Smith, A. C. Mertens, Y. Liu, S. Hammond, C. E. Land, J. P. Neglia and P. D. Inskip, Thyroid cancer in childhood cancer survivors: A detailed evaluation of radiation dose response and its modifiers. Radiat. Res. 166, 618-628 (2006).
2. A. J. Sigurdson, C. M. Ronckers, A. C. Mertens, M. Stovall, S. A. Smith, Y. Liu, R. L. Berkow, S. Hammond, J. P. Neglia and P. D. Inskip, Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 365, 2014-2023 (2005).
3. F. de Vathaire, C. Hardiman, A. Shamsaldin, S. Campbell, E. Grimaud, M. Hawkins, M. Raquin, O. Oberlin, I. Diallo and C. Bonaïti, Thyroid carcinomas after irradiation for a first cancer during childhood. Arch. Intern. Med. 159, 2713-2719 (1999).
4. A. J. Taylor, A. P. Croft, A. M. Palace, D. L. Winter, R. C. Reulen, C. A. Stiller, M. C. Stevens and M. M. Hawkins, Risk of thyroid cancer in survivors of childhood cancer: Results from the British Childhood Cancer Survivor Study. Int. J. Cancer 125, 2400-2405 (2009).
5. M.A.Tucker, P.H.Jones, J.D.Boice,Jr.,L.L.Robison,B.J. Stone, M. Stovall, R. D. Jenkin, J. H. Lubin, E. S. Baum and the Late Effects Study Group, Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res. 51, 2885-2888 (1991).
6. L. L. Robison, G. T. Armstrong, J. D. Boice, E. J. Chow, S. M. Davies, S. S. Donaldson, D. M. Green, S. Hammond, A. T. Meadows and L. K. Zeltzer, The Childhood Cancer Survivor Study: A National Cancer Institute-supported resource for outcome and intervention research. J. Clin. Oncol. 27, 2308-2318 (2009).
7. L. L. Robison, A. C. Mertens, J. D. Boice, N. E. Breslow, S. S. Donaldson, D. M. Green, F. P. Li, A. T. Meadows, J. J. Mulvihill and L. K. Zeltzer, Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med. Pediatr. Oncol. 38, 229-239 (2002).
8. M. Stovall, C. R. Blackwell, J. Cundiff, D. H. Novack, J. R. Palta, L. K. Wagner, E. W. Webster and R. J. Shalek, Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group No. 36. Med. Phys. 22, 63-82 (1995).
9. M. Stovall, S. A. Smith and M. Rosenstein, Tissue doses from radiotherapy of cancer of the uterine cervix. Med. Phys. 16, 726-733 (1989).
10. Central axis depth dose data for use in radiotherapy. A survey of depth doses and related data measured in water or equivalent media. Br. J. Radiol. Suppl. 17, 1-147 (1983).
11. P. D. Inskip, Thyroid cancer after radiotherapy for childhood cancer. Med. Pediatr. Oncol. 36, 568-573 (2001).
12. R. E. Shore, Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat. Res. 131, 98-111 (1992).
13. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2006). National Cancer Institute, Bethesda, MD, 2009. [Available online at www.seer.cancer.gov/popdata]
14. D. J. Brenner, R. Doll, D. T. Goodhead, E. J. Hall, C. E. Land, J. B. Little, J. H. Lubin, D. L. Preston, R. J. Preston and M. Zaider, Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc. Natl. Acad. Sci. USA 100, 13761-13766 (2003).
15. L. H. Gray, Radiation biology and cancer. In Cellular Radiation Biology: A collection of works presented at the 18th Annual Symposium on Experimental Cancer Research 1964, pp. 7-25. Williams and Wilkins, Baltimore, 1965.
16. 131I in childhood. J. Natl. Cancer Inst. 97, 724-732 (2005). (Pubitemid 40872379)
17. S. Davis, V. Stepanenko, N. Rivkind, K. J. Kopecky, P. Voilleque, V. Shakhtarin, E. Parshkov, S. Kulikov, E. Lushnikov and A. Tsyb, Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat. Res. 162, 241-248 (2004).
18. R. A. Kerber, J. E. Till, S. L. Simon, J. L. Lyon, D. C. Thomas, S. Preston-Martin, M. L. Rallison, R. D. Lloyd and W. Stevens, A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. J. Am. Med. Assoc. 270, 2076-2082 (1993).
19. I. Likhtarov, L. Kovgan, S. Vavilov, M. Chepurny, E. Ron, J. Lubin, A. Bouville, N. Tronko, T. Bogdanova and G. Howe, Post-Chernobyl thyroid cancers in Ukraine. Report 2: Risk analysis. Radiat. Res. 166, 375-386 (2006).
20. D. L. Preston, E. Ron, S. Tokuoka, S. Funamoto, N. Nishi, M. Soda, K. Mabuchi and K. Kodama, Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 168, 1-64 (2007).
21. E. Ron, J. H. Lubin, R. E. Shore, K. Mabuchi, B. Modan, L. M. Pottern, A. B. Schneider, M. A. Tucker and J. D. Boice, Jr., Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 141, 259-277 (1995).
22. S. Sadetzki, A. Chetrit, A. Lubina, M. Stovall and I. Novikov, Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J. Clin. Endocrinol. Metab. 91, 4798-4804 (2006).
23. M. D. Tronko, G. R. Howe, T. I. Bogdanova, A. C. Bouville, O. V. Epstein, A. B. Brill, I. A. Likhtarev, D. J. Fink, V. V. Markov and G. W. Beebe, A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: thyroid cancer in Ukraine detected during first screening. J. Natl. Cancer Inst. 98, 897-903 (2006).
24. E. S. Gilbert, M. Stovall, M. Gospodarowicz, F. E. Van Leeuwen, M. Andersson, B. Glimelius, T. Joensuu, C. F. Lynch, R. E. Curtis and L. B. Travis, Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat. Res. 159, 161-173 (2003).
25. P. D. Inskip, L. L. Robison, M. Stovall, S. A. Smith, S. Hammond, A. C. Mertens, J. A. Whitton, L. Diller, L. Kenney and J. P. Neglia, Radiation dose and breast cancer risk in the childhood cancer survivor study. J. Clin. Oncol. 27, 3901-3907 (2009).
26. B. Le Vu, F. de Vathaire, A. Shamsaldin, M. M. Hawkins, E. Grimaud, C. Hardiman, I. Diallo, G. Vassal, E. Bessa and J. Lemerle, Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int. J. Cancer 77, 370-377 (1998).
27. L. B. Travis, D. A. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund and E. Gilbert, Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. J. Am. Med. Assoc. 290, 465-475 (2003).
28. M. A. Tucker, G. J. D'Angio, J. D. Boice, Jr., L. C. Strong, F. P. Li, M. Stovall, B. J. Stone, D. M. Green, F. Lombardi and the Late Effects Study Group, Bone sarcomas linked to radiotherapy and chemotherapy in children. N. Engl. J. Med. 317, 588-593 (1987).
29. J. D. Boice, Jr., M. Blettner, R. A. Kleinerman, M. Stovall, W. C. Moloney, G. Engholm, D. F. Austin, A. Bosch, D. L. Cookfair and G. B. Hutchison, Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl. Cancer Inst. 79, 1295-1311 (1987).